Overview
Valentis Polska offers more than 250 products in areas including immunity, skin health, joint health, digestion and sleep. The company develops products and provides contract manufacturing of tablets, capsules, liquids, solutions and powders, including private-label products. It operates two production facilities in the European Union, producing more than 15 million packages a year.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $318,372 |
Filing timeliness
Financial statements were filed on time, on average 24 days early. 4 of 6 audited by a statutory auditor.
- 202510/07/2026
- 202411/07/2025
- 202303/07/2024
- 202215/07/2023
- 202129/06/2022
- 202028/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Dietary supplements
- Multivitamin preparations
- Liposomal products
- Product development
- Contract manufacturing
- Pharmaceutical packaging
- Laboratory testing
- Product logistics
Website technology
- Website
- WordPress
Authorized Representatives
Manner of representation
Each member of the management board is authorized to submit declarations of will on behalf of the company independently, and, if a commercial proxy has been appointed, the commercial proxy independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Andrzej Robert Kultysage 59 | 2,000 | $54,024.85 | 25% |
Uab Litnovia | 6,000 | $162,074.55 | 75% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2006-10-01.
71 1240 6003 1111 0000 4941 0415- 93 1240 1040 1111 0010 9064 3737
71 1140 1977 0000 3187 3000 1001
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 220PLN 220 |
Public aid
7 public aid cases recorded, with a total value of $390,896.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 24, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $1,408$1,408 | Prezydent Miasta Stołecznego Warszawy | |
| Sep 29, 2020 | Other crisis aid | $17,635$17,635 | Prezydent Miasta Stołecznego Warszawy | |
| Jul 1, 2020 | Other crisis aid | $14,108$14,108 | Prezydent Miasta Stołecznego Warszawy |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Ursapharm Polandsp. z o.o. | $16,296,973.60 | ursapharm.pl | ||
| Qpharmasp. z o.o. | $16,010,159.04 | qpharma.pl | ||
| Werfen Polskasp. z o.o. | $14,536,720.51 | werfen.com | ||
| Vitamed Pharmaceuticalssp. z o.o. | $14,515,124.01 | vitamed.pl | ||
| AO East Europesp. z o.o. | $13,998,610.57 | aoeasteurope.pl | ||
| Pharmabestsp. z o.o. | $13,942,252.57 | pharmabest.pl | ||
| Allpharm sp. z o.o.sp. k. | $13,461,628.01 | allpharm.pl | ||
| Medif sp. z o.o.sp. k. | $13,126,958.83 | medif.com | ||
| Artivion Polskasp. z o.o. | $12,154,890.49 | artivion.com | ||
| Panawitsp. z o.o. | $10,791,432.08 | panawit.pl |
Change history
FAQ
Last updated: 2026-07-16